Erik Rasmussen Selected Research

Erik Rasmussen Research Topics

Disease

13	Neoplasms (Cancer) 01/2021 - 07/2009
6	Multiple Myeloma 01/2021 - 12/2003
6	Fatigue 10/2020 - 06/2014
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2015
3	Edema (Dropsy) 10/2020 - 06/2014
3	Ovarian Neoplasms (Ovarian Cancer) 12/2018 - 05/2012
3	Hypertension (High Blood Pressure) 11/2014 - 02/2008
2	Colorectal Neoplasms (Colorectal Cancer) 10/2020 - 08/2015
2	Exanthema (Rash) 10/2020 - 06/2014
2	Bites and Stings (Sting) 10/2020 - 01/2012
2	Glioblastoma (Glioblastoma Multiforme) 01/2020 - 01/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2019 - 07/2017
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2019 - 06/2014
2	Prostatic Neoplasms (Prostate Cancer) 12/2018 - 10/2014
2	Nausea 10/2017 - 11/2014
2	Chronic Hepatitis B 03/2016 - 09/2015
2	Infections 09/2015 - 01/2014
2	Diarrhea 10/2014 - 06/2014
2	Cardiotoxicity 09/2010 - 12/2009
2	Disease Progression 06/2010 - 03/2006
1	Pancreatic Neoplasms (Pancreatic Cancer) 10/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2020
1	Liposarcoma 01/2020
1	Cytopenia 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioma (Gliomas) 01/2019
1	Triple Negative Breast Neoplasms 12/2018
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2015
1	Vomiting 11/2014
1	Epistaxis (Nosebleed) 11/2014
1	Constipation 11/2014
1	Contusions 10/2014
1	Atrophy 10/2014
1	Wounds and Injuries (Trauma) 01/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 06/2010

Drug/Important Bio-Agent (IBA)

7	trebananibIBA 08/2015 - 07/2009
4	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 06/2010
3	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2019
3	Angiopoietin-1IBA 09/2016 - 06/2010
2	pembrolizumabIBA 01/2021 - 10/2020
2	Monoclonal AntibodiesIBA 10/2020 - 01/2018
2	Macrophage Colony-Stimulating FactorIBA 10/2020 - 10/2017
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2020 - 10/2017
2	2- (5- (3- chlorophenyl)- 6- (4- chlorophenyl)- 1- (1- (isopropylsulfonyl)- 3- methylbutan- 2- yl)- 3- methyl- 2- oxopiperidin- 3- yl)acetic acidIBA 01/2020 - 01/2019
2	N- (4- ((3- (2- amino- 4- pyrimidinyl)- 2- pyridinyl)oxy)phenyl)- 4- (4- methyl- 2- thienyl)- 1- phthalazinamineIBA 12/2018 - 07/2017
2	Aurora KinasesIBA 12/2018 - 07/2017
2	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 06/2010
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 08/2004
2	InterferonsIBA 03/2016 - 09/2015
2	Interferon-alpha (Interferon Alfa)IBA 09/2015 - 12/2004
2	Docetaxel (Taxotere)FDA Link 08/2015 - 06/2010
2	Pharmaceutical PreparationsIBA 08/2015 - 06/2015
2	Carboplatin (JM8)FDA LinkGeneric 08/2015 - 06/2010
2	Melphalan (Alkeran)FDA LinkGeneric 03/2006 - 12/2004
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	abemaciclibIBA 01/2021
1	RamucirumabIBA 01/2021
1	LigandsIBA 10/2020
1	B-Cell Maturation AntigenIBA 10/2020
1	epidermal growth factor receptor VIIIIBA 01/2019
1	ErbB Receptors (EGF Receptor)IBA 01/2019
1	AMG 595IBA 01/2019
1	trametinibIBA 01/2019
1	taxaneIBA 12/2018
1	PlatinumIBA 12/2018
1	Etoposide (VP 16)FDA LinkGeneric 12/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2018
1	GlucocorticoidsIBA 01/2018
1	Alkaline PhosphataseIBA 10/2017
1	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2016
1	Antiviral Agents (Antivirals)IBA 09/2015
1	AMG623 peptibodyIBA 08/2015
1	liposomal doxorubicin (Doxil)FDA Link 08/2015
1	Capecitabine (Xeloda)FDA Link 08/2015
1	Lapatinib (GW572016)FDA Link 08/2015
1	Topotecan (Hycamtin)FDA LinkGeneric 08/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2015
1	Angiopoietin-2IBA 06/2015
1	Bevacizumab (Avastin)FDA Link 11/2014
1	motesanib diphosphateIBA 11/2014
1	AndrogensIBA 10/2014
1	MyostatinIBA 10/2014
1	AMG 745IBA 10/2014
1	Sunitinib (Sutent)FDA Link 06/2014
1	Sorafenib (BAY 43-9006)FDA Link 06/2014
1	CytokinesIBA 01/2014
1	ChemokinesIBA 01/2014
1	Tenofovir (Viread)FDA Link 01/2014
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2014
1	TubulinIBA 09/2010
1	Gemcitabine FDA Link 06/2010
1	Biomarkers (Surrogate Marker)IBA 06/2010
1	Hydralazine (Apresoline)FDA LinkGeneric 12/2009
1	Troponin IIBA 12/2009

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2004
4	Drug Therapy (Chemotherapy) 12/2018 - 03/2006
1	Castration 12/2018
1	Negative-Pressure Wound Therapy 01/2012